Sonia Sidhu
- Born
- January 3, 1968 — India
- Family
- Married to Gurjit, twin daughters and a son
- Career
- Over 18 years in the healthcare field as a diabetes educator and research coordinator
- Political Experience
- Elected as a Member of Parliament for Brampton South in 2015. Sat on the House of Commons’ Standing Committee on Health, and also was appointed to sit as a member of the Special Committee on Pay Equity. Vice-Chair of the Standing Committee on the Status of Women as well as the Chair and the Liberal caucus champion for the All-Party Diabetes Caucus. General-Secretary of the Canada-India Parliamentary Friendship Group and an executive member of both the Canada-Poland and Canada-Portugal Parliamentary Friendship Groups. Member of the Canada-Europe Parliamentary Association, the Canada-U.S. Inter-Parliamentary Group, and the Commonwealth Parliamentary Association.
- Notable
- Private member bill An Act to establish a national framework for diabetes (Bill C-237) was adopted.
Where Sonia falls on key policy spectrums
Your Money
People & Society
How We're Governed
Land & Community
Mr. Speaker, today on World Tuberculosis Day, we reflect on our progress and the work still ahead. TB is preventable, treatable and curable, yet it continues to affect thousands of people, including here in Canada. In recent years, over 2,500 people in Canada have been diagnosed. Yesterday, Health Canada approved a new drug that will expand access to shorter, safer preventive TB treatment. [more]
Thank you, Mr. Chair. Thank you, witnesses. My question is for Mr. Watson. If the federal government were to adopt a national strategy of pharmaceutical sovereignty, what three priorities do you believe should be at the centre of ensuring Canadians have reliable, affordable access to essential medicine? You already talked about sustainable pricing, but give three priorities, if you can speak [more]
To follow up on that, from an industry perspective, what types of tax incentives, such as tax credits or regulatory reforms or direct investments, would most effectively encourage companies to expand pharmaceutical manufacture in Canada?
I just want a clarification. I'm hearing here that Health Canada's approval of any drug is done in 180 days. I think there are major delays in approvals after that, after Health Canada's approval. I think there is more procedure on that, but Health Canada's record for the approval of any new drug is 180 days.